Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;

Multidisciplinary Delphi study on residual risk in patients with chronic kidney disease and type 2 diabetes mellitus Alberto Ortiz; Ana Cebrián; Alfonso Soto; Andrés Reyes; Jose Luis Górriz;